financetom
Business
financetom
/
Business
/
Mercedes-Benz takes stake in robotics maker Apptronik, tests robots in factories
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mercedes-Benz takes stake in robotics maker Apptronik, tests robots in factories
Mar 18, 2025 8:35 AM

BERLIN (Reuters) - Mercedes-Benz is trialling using humanoid robots made by U.S.-based company Apptronik for tasks such as moving components to the production line or carrying out quality checks, the latest automaker to experiment with robots in manufacturing.

The German company has invested a low double-digit million-euro sum in Apptronik, a Texas-based firm founded in 2016 that is racing with the likes of Tesla and Nvidia ( NVDA )-backed Figure AI to scale up production of AI-powered human-like robots.

A handful of Apptronik's "Apollo" robots have been trained for specific tasks within Mercedes-Benz's production process through so-called 'teleoperation', where the robot is operated remotely by humans and learns the tasks it performs, with the goal of eventually being able to repeat them autonomously.

The carmaker is testing use of the robots at its Digital Factory Campus in Marienfelde, Berlin, and in Kecskemet, Hungary, and plans to bring them to other sites, production chief Joerg Burzer said in a roundtable with journalists in Berlin on Tuesday.

"I'd like to see us find applications in areas where we face labour shortages - but of course first for the repetitive tasks, and then hazardous ones," Burzer added.

"The cost will be decisive... when costs reach a two-digit thousand-dollar sum - which is absolutely possible - it will become very interesting," he said, without giving a timeframe or the current cost per robot.

Carmakers including Honda ( HMC ), Hyundai, and BMW have experimented with humanoid robots to perform repetitive tasks that could be dangerous or tedious, though none has yet deployed them in manufacturing at large scale.

Tesla CEO Elon Musk said last April he "guessed" the Tesla robot, called Optimus, could perform tasks in the factory by year-end, but has not since provided an update.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
May 1, 2024
May 2 (Reuters) - BioCatch: * PERMIRA TO ACQUIRE MAJORITY POSITION IN BIOCATCH AT $1.3BN VALUATION * BIOCATCH - UNDER THE TERMS OF THE AGREEMENT, THE FUND WILL ACQUIRE A MAJORITY STAKE IN BIOCATCH * BIOCATCH - TRANSACTION IS EXPECTED TO ACCELERATE THE COMPANY'S GLOBAL EXPANSION Source text for Eikon: Further company coverage: ...
Oil prices rebound on prospect of US replenishing strategic reserve
Oil prices rebound on prospect of US replenishing strategic reserve
May 1, 2024
NEW DELHI (Reuters) -Oil prices rose on Thursday, rebounding from three days of losses, on expectations the lower levels may prompt the U.S., the world's biggest crude consumer, to start replenishing its strategic reserve, putting a floor under prices. Still, prices fell more than 3% on Wednesday to a seven-week after the U.S. Federal Reserve kept interest rates steady, which...
Standard Chartered Q1 profit rises 5.5%, beats estimates
Standard Chartered Q1 profit rises 5.5%, beats estimates
May 1, 2024
HONG KONG, May 2 (Reuters) - Standard Chartered PLC ( SCBFF ) posted on Thursday a 5.5% rise in its first-quarter pretax profit, beating estimates, as higher interest rates bolstered earnings at the emerging markets-focused lender. StanChart, which earns most of its revenue in Asia, said statutory pretax profit in the quarter was $1.91 billion. That compared with $1.81 billion...
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
May 1, 2024
* UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro * Competition for customers raises concerns over patient aftercare * Users of the drugs need medical supervision By Ludwig Burger May 2 (Reuters) - Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply...
Copyright 2023-2026 - www.financetom.com All Rights Reserved